Skip to content
10-K

Annual Report

TREVI THERAPEUTICS, INC. TRVI

0001193125-26-110783

← back to feed
Filed
Mar 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 12, 2026 128.4M sh
Shares Diluted FY 2025 · Dec 31, 2025 134.75M sh
Shares Diluted FY 2025 · Dec 31, 2024 101.97M sh
Capex FY 2025 · Dec 31, 2025 $12K
Capex FY 2025 · Dec 31, 2024 $35K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$42.09M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$38.26M
Cash And Equivalents FY 2025 · Dec 31, 2025 $18.91M
Cash And Equivalents FY 2025 · Dec 31, 2024 $34.1M
Stockholders Equity FY 2025 · Dec 31, 2025 $183.24M
Stockholders Equity FY 2025 · Dec 31, 2024 $99.64M
Stockholders Equity FY 2025 · Dec 31, 2023 $82.55M
Current Liabilities FY 2025 · Dec 31, 2025 $9.75M
Current Liabilities FY 2025 · Dec 31, 2024 $10.51M
Total Liabilities FY 2025 · Dec 31, 2025 $10.2M
Total Liabilities FY 2025 · Dec 31, 2024 $11.26M
Current Assets FY 2025 · Dec 31, 2025 $191.66M
Current Assets FY 2025 · Dec 31, 2024 $109.43M
Total Assets FY 2025 · Dec 31, 2025 $193.44M
Total Assets FY 2025 · Dec 31, 2024 $110.9M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.32
Eps Diluted FY 2025 · Dec 31, 2024 −$0.47
Eps Basic FY 2025 · Dec 31, 2025 −$0.32
Eps Basic FY 2025 · Dec 31, 2024 −$0.47
Sga Expense FY 2025 · Dec 31, 2025 $15.85M
Sga Expense FY 2025 · Dec 31, 2024 $12.15M
Rd Expense FY 2025 · Dec 31, 2025 $33.48M
Rd Expense FY 2025 · Dec 31, 2024 $39.38M
Net Income FY 2025 · Dec 31, 2025 −$42.76M
Net Income FY 2025 · Dec 31, 2024 −$47.91M
Operating Income FY 2025 · Dec 31, 2025 −$49.33M
Operating Income FY 2025 · Dec 31, 2024 −$51.52M